Drugs Made In Stock Market Value
| DMAA Stock | 10.44 0.01 0.1% |
| Symbol | Drugs |
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. Projected growth potential of Drugs fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Drugs Made assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Drugs Made's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Drugs Made should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Drugs Made's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Drugs Made 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Drugs Made's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Drugs Made.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Drugs Made on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Drugs Made In or generate 0.0% return on investment in Drugs Made over 90 days. Drugs Made is related to or competes with SIM Acquisition, Mountain Lake, Berto Acquisition, Centurion Acquisition, Berto Acquisition, Live Oak, and Titan Acquisition. Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange. More
Drugs Made Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Drugs Made's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Drugs Made In upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1641 | |||
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 0.5781 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.194 |
Drugs Made Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Drugs Made's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Drugs Made's standard deviation. In reality, there are many statistical measures that can use Drugs Made historical prices to predict the future Drugs Made's volatility.| Risk Adjusted Performance | 0.061 | |||
| Jensen Alpha | 0.0073 | |||
| Total Risk Alpha | 0.0024 | |||
| Sortino Ratio | (0.17) | |||
| Treynor Ratio | 0.8081 |
Drugs Made February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.061 | |||
| Market Risk Adjusted Performance | 0.8181 | |||
| Mean Deviation | 0.0789 | |||
| Downside Deviation | 0.1641 | |||
| Coefficient Of Variation | 636.09 | |||
| Standard Deviation | 0.1119 | |||
| Variance | 0.0125 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | 0.0073 | |||
| Total Risk Alpha | 0.0024 | |||
| Sortino Ratio | (0.17) | |||
| Treynor Ratio | 0.8081 | |||
| Maximum Drawdown | 0.5781 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.194 | |||
| Downside Variance | 0.0269 | |||
| Semi Variance | (0.01) | |||
| Expected Short fall | (0.14) | |||
| Skewness | (0.05) | |||
| Kurtosis | 1.42 |
Drugs Made In Backtested Returns
At this point, Drugs Made is very steady. Drugs Made In secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Drugs Made In, which you can use to evaluate the volatility of the firm. Please confirm Drugs Made's Mean Deviation of 0.0789, coefficient of variation of 636.09, and Standard Deviation of 0.1119 to check if the risk estimate we provide is consistent with the expected return of 0.019%. Drugs Made has a performance score of 13 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0094, which means not very significant fluctuations relative to the market. As returns on the market increase, Drugs Made's returns are expected to increase less than the market. However, during the bear market, the loss of holding Drugs Made is expected to be smaller as well. Drugs Made In right now shows a risk of 0.11%. Please confirm Drugs Made In downside variance, kurtosis, and the relationship between the value at risk and expected short fall , to decide if Drugs Made In will be following its price patterns.
Auto-correlation | 0.80 |
Very good predictability
Drugs Made In has very good predictability. Overlapping area represents the amount of predictability between Drugs Made time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Drugs Made In price movement. The serial correlation of 0.8 indicates that around 80.0% of current Drugs Made price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.8 | |
| Spearman Rank Test | 0.88 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Drugs Made In is a strong investment it is important to analyze Drugs Made's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Drugs Made's future performance. For an informed investment choice regarding Drugs Stock, refer to the following important reports:Check out Drugs Made Correlation, Drugs Made Volatility and Drugs Made Performance module to complement your research on Drugs Made. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Drugs Made technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.